[COLL] YoY Quarter Result on 30-Jun-2024 [#Q2]

Stock
[COLL] Collegium Pharmaceutical, Inc.
Announcement Date
08-Aug-2024
Financial Year
2024
Quarter
30-Jun-2024 [#Q2]
Profit Trend
QoQ- -29.25%
YoY- 50.73%
Quarter Report
COLL's Result
COLL's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 145,276 135,546 123,549 82,942 78,058 75,040 73,061 12.12%
PBT 29,097 17,797 -6,646 10,991 8,304 -4,712 -13,060 -
Tax 9,491 4,790 -1,455 -61,852 246 -296 6,158 7.46%
NP 19,606 13,007 -5,191 72,843 8,058 -4,712 -13,060 -
Tax Rate -32.62% -26.91% - 562.75% -2.96% - - -
Total Cost 125,670 122,539 128,740 10,099 70,000 79,752 86,121 6.49%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 13.50 9.60 -4.20 87.82 10.32 -6.28 -17.88 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS 0.60 0.38 -0.15 2.06 0.23 -0.14 -0.40 -
EPS Diluted 0.52 0.34 -0.15 1.79 0.23 -0.14 -0.40 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.